| Literature DB >> 35273989 |
Min Yang1,2, Liang Tao1,2,3, Cun-Chao Zhao2,3, Zi-Lin Wang1,2, Zhi-Jin Yu1,3, Wen Zhou1, Yan-Long Wen1,2, Ling-Fei Li1,2, Yang Tian1,2,3, Jun Sheng2,4.
Abstract
Fatigue is a common physiological phenomenon caused by many complicated factors. Excessive fatigue will lead to a series of uncomfortable reactions and damage body health. Panax notoginseng leaves (PNL) is a new resource food that good for soothing nerves, nourishing the heart, and strengthening the spleen. Microbial fermentation could increase the content of bio-ingredients and produce new active ingredients. However, the effect of fermented P. notoginseng leaves (FPNL) on antifatigue and the molecular mechanisms remain to be elucidated. Thus, in this study, we evaluated the antifatigue effect of co-fermented P. notoginseng leaves by Saccharomyces cerevisiae and Bacillus subtilis in-vitro and in-vivo, and its mechanism was further elucidated. The results showed that FPNL exhibited higher saponins, organic phenolic acids content, and antioxidant activity than PNL. FPNL improved ISO-induced H9c2 myocardial cell damage by alleviating apoptosis (modulating Bax and Bcl-2 protein expression) and reducing antioxidant activity in-vitro. Moreover, in-vivo experiment showed that FPNL significantly prolonged the weight-loading swimming time of mice. After gavaged FPNL, the levels of liver glycogen (LG) and serum lactate dehydrogenase (LDH) activity were increased in mice. In contrast, the levels of blood urea nitrogen (BUN), lactate acid, and malondialdehyde (MDA) were decreased. In summary, our results indicated that FPNL showed a good antifatigue effect in-vivo and in-vitro.Entities:
Keywords: Panax notoginseng leaves; antifatigue; antioxidant; fermentation; microbial; weight-loading swimming
Year: 2022 PMID: 35273989 PMCID: PMC8904179 DOI: 10.3389/fnut.2022.824525
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Contents of total polyphenols, flavonoids, and saponins in PNL and FPNL.
|
|
|
|
|
|---|---|---|---|
|
|
|
| |
| PNL | 38.26 ± 3.57 | 25 ± 4.87 | 161.584 ± 3.13 |
| FPNL | 63.75 ± 4.16 | 54.72 ± 2.85 | 192.861 ± 2.82 |
Figure 1HPLC analysis of different saponins content in PNL and FPNL. (A) A stander mixture of four saponins. (B) The four saponins in PNL. (C) The four saponins in FPNL.
Figure 2Changes of ABTS and DPPH free radical scavenging rates of PNL and FPNL. (A) Changes in ABTS rates of PNL and FPNL. (B) Changes in DPPH rates of PNL and FPNL. *P < 0.05, **P < 0.01 vs. PNL group.
Figure 3Identification of discriminating biomarkers of fermented P. notoginseng leaves metabolomics analysis. (A) The OPLS-DA score plot in ion mode. (B) The PCA score plot in ion mode. (C) The H volcanic figure plot in ion mode. (D) The validation plot for the OPLS-DA model is built for negative, the slope of R2 is greater than 0, and the intercept of Q2 on the Y-axis is less than 0.05, indicating a valid model, the scattered shape and color of Figure. Three represent disparate studied groups.
Figure 4Improvement of different metabolites of PNL and FPNL. (A) Bubble plot displays the increasing impact of the enrichment analysis of metabolic pathways, with key bubbles reflecting that the metabolic pathways were significantly altered by fermentation. (B) Heatmap clearly shows the relationship in potential biomarkers after fermentation. (C) Chord diagram of metabolic differences. (D) Metabolites differential enrichment map.
The variations in P. notoginseng leaves metabolites after fermented.
|
|
|
|
|
|
|---|---|---|---|---|
| 4′Hydroxyflurbiprofen | 1.4236 | 0.000322 | 0.2550 | −1.9712 |
| Beta-leucine | 1.4254 | 0.000140 | 0.2909 | −1.7812 |
| 4-Hydroxystyrene | 1.4244 | 0.00031 | 14.1641 | 3.8241 |
| Deoxycytidine | 1.4163 | 0.00027 | 0.0351 | −4.8291 |
| Piperidine | 1.4214 | 0.00030 | 0.3596 | −1.4752 |
| Pyrocatechol | 1.4226 | 0.000319 | 5.1849 | 2.3742 |
| Artonin t | 1.4218 | 0.000362 | 0.2299 | −2.1204 |
| 3,3,5-Triiodothyronine-beta-glucuronoside | 1.4214 | 0.00210 | 0.3509 | −1.5107 |
| Clenbuterol | 1.4236 | 0.0002367 | 0.20421 | −2.29187 |
| Methylimidazoleacetic acid | 1.3927 | 0.0001182 | 29.4480 | 4.8809 |
| Proline | 1.4248 | 0.0002815 | 3.46094 | 1.79116 |
| Oxoproline | 1.4214 | 0.0002703 | 0.16272 | −2.61946 |
| Citric acid | 1.4212 | 0.0001197 | 0.118788 | −3.07352 |
| Ribothymidine | 1.4240 | 0.0002998 | 0.32737 | −1.61098 |
| Hypogeic acid | 1.4232 | 0.0002173 | 3.26973 | 1.70917 |
| Fumaric acid | 1.4107 | 0.0002565 | 0.067328 | −3.89263 |
| Isoleucine | 1.1699 | 0.0002199 | 0.48346 | −1.04850 |
| Indolelactic acid | 1.4203 | 0.0000845 | 53.38945 | 5.73841 |
| Phenylacetic acid | 1.4241 | 0.0001078 | 0.008551 | −6.86956 |
| Benzoic acid | 1.4235 | 0.0002099 | 3.448989 | 1.786173 |
| Oxypinnatanine | 1.4225 | 0.0001560 | 0.457686 | −1.275697 |
| Shikimic acid | 1.4244 | 0.0002616 | 0.583155 | −0.778048 |
| 4-Hydroxybutyrate | 1.2262 | 0.0000176 | 682.8043 | 9.41532 |
| Sparfloxacin | 1.4233 | 0.0002161 | 2.82629 | 1.49891 |
| Erythrose 2 | 1.4237 | 0.0003457 | 4.366523 | 2.12648 |
| Trans-aconitic acid | 1.4185 | 0.0002928 | 0.359388 | −1.476384 |
| Succinic anhydride | 1.4244 | 0.0001543 | 7.521064 | 2.910931 |
| Fertaric acid | 1.4232 | 0.00018291 | 0.272257 | −1.876595 |
| 12-Oxo-2,3-dinor 10,15-phytodienoic acid | 1.4191 | 0.00029548 | 2.504321 | 1.32443 |
| Analyte | 1.4247 | 0.00012273 | 0.09360 | −3.417341 |
Figure 5The effect of PNL and FPNL on ISO-induced H9c2 cell apoptosis. (A) Alleviated of the proliferation of H9c2 cells by different concentrations of FPNL. (B) Alleviated of the proliferation of H9c2 cells by different concentrations of PNL. (C–E) Expression of apoptotic proteins (Bax, Bcl-2) in HCT116 cells. Data are expressed as mean ± SEM from three independent experiments (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 vs. control. P < 0.05, P < 0.01, P < 0.001 vs. FPNL (160 μg/ml) group.
Figure 6Fermented P. notoginseng leaves alleviates fatigues in swimming mice. (A) Loading swimming experimental design. (B) Swimming time with weight loading after gavage PNL and FPNL. (C) Body weight, measured every 4 days. Data are expressed as mean ± SEM from six independent parallel experiments (n = 6). **P < 0.01, ***P < 0.001, ****P < 0.0001 vs. control. P < 0.001 vs. FPNL (200 mg/kg) group.
Organ weight of mice.
|
|
|
|
| ||
|---|---|---|---|---|---|
|
|
|
|
|
| |
| Heart | 0.23 ± 0.20 | 0.22 ± 0.13 | 0.21 ± 0.13 | 0.25 ± 0.12 | 0.24 ± 0.22 |
| Liver | 1.62 ± 0.1 | 1.65 ± 0.08 | 1.64 ± 0.14 | 1.67 ± 0.13 | 1.63 ± 0.17 |
| Lungs | 0.31 ± 0.15 | 0.33 ± 0.11 | 0.35 ± 0.16 | 0.38 ± 0.15 | 0.35 ± 0.18 |
| Spleen | 0.16 ± 0.2 | 0.19 ± 0.07 | 0.15 ± 0.11 | 0.17 ± 0.17 | 0.18 ± 0.15 |
| Kidney | 0.58 ± 0.13 | 0.60 ± 0.20 | 0.61 ± 0.12 | 0.63 ± 0.21 | 0.56 ± 0.14 |
Figure 7Effect of fermented P. notoginseng leaves and P. notoginseng leaves on LG BUN, MDA level in serum. (A) The LG level in mice serum after swimming. (B) The BUN level in mice serum after swimming. (C) The MDA level in mice serum after swimming. Data are expressed as mean ± SEM from six independent experiments (n = 6). *P < 0.05, **P < 0.01, ***P < 0.001 vs. control. P < 0.05 vs. FPNL (200 mg/kg) group.
Figure 8Effect of fermented P. notoginseng leaves and P. notoginseng leaves on LD, LDH level in serum. (A) The LD level in mice serum after swimming. (B) The LDH level in mice serum after swimming. Data are expressed as mean ± SEM from six independent experiments (n = 6). *P < 0.05, **P < 0.01, ***P < 0.001 vs. control. P < 0.05 vs. FPNL (200 mg/kg) group.